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Accumulating evidence suggests that protein-protein
interactions play an important role in transepithelial
ion transport. In the present study, we report on the
biochemical and functional association between cystic
fibrosis transmembrane conductance regulator (CFTR)
and a PDZ domain-containing protein Shank2. Explora-
tory reverse transcription-PCR screening revealed
mRNAs for several members of PDZ domain-containing
proteins in epithelial cells. Shank2, one of these scaf-
folding proteins, showed a strong interaction with
CFTR by yeast two-hybrid assays. Shank2-CFTR inter-
action was verified by co-immunoprecipitation experi-
ments in mammalian cells. Notably, this interaction was
abolished by mutations in the PDZ domain of Shank2.
Protein phosphorylation, HCO3
 transport and Cl cur-
rent by CFTR were measured in NIH 3T3 cells with
heterologous expression of Shank2. Of interest, expres-
sion of Shank2 suppressed cAMP-induced phosphoryla-
tion and activation of CFTR. Importantly, loss of Shank2
by stable transfection of antisense-hShank2 plasmid
strongly increased CFTR currents in colonic T84 cells,
in which CFTR and Shank2 were natively expressed.
Our results indicate that Shank2 negatively regulates
CFTR and that this may play a significant role in main-
taining epithelial homeostasis under normal and dis-
eased conditions such as those presented by secretory
diarrhea.
Secretory epithelia perform vectorial transport of salt and
water molecules by coordinated actions of the transporters
expressed in polarized epithelial membranes. One of the key
membrane proteins regulating overall fluid movements is the
cystic fibrosis transmembrane conductance regulator (CFTR),1
which itself has an anion-transporting activity (1–3). Aberrant
membrane transport caused by either hypo- or hyper-function-
ing of CFTR, can be detrimental, and may result in life-threat-
ening diseases, such as cystic fibrosis or secretory diarrhea (4,
5). Therefore, the fine regulation of salt and water transport is
essential in epithelial and body homeostasis.
Accumulating evidence suggests that protein-protein inter-
action performs an important role in the regulation of transepi-
thelial ion transport (6). Clustering of ion transporters and
associated proteins in microdomains of polarized epithelia can
facilitate the effective secretion or absorption of salt and water
molecules. In this regard, modular adaptor proteins such as
PDZ (PSD-95/discs large/ZO-1) domain-containing proteins
have drawn increasing attention due to their ability to form
supramolecular complexes (7). We have previously shown that
the regulatory interaction between CFTR and Na/H ex-
changer 3 (NHE3) through PDZ-based scaffolds is essential for
the coordinated regulation of pancreatic bicarbonate secretion
(8). In addition, it was found that a number of membrane
transporters and receptors participating in pancreatic fluid
formation, such as Na-HCO3
 cotransporters (NBC), puriner-
gic receptors, and secretin receptors have a PDZ-binding motif
on their C terminus (9, 10). Therefore, multiple protein inter-
actions through PDZ-based scaffolds are believed to perform a
critical role in fluid secretion by pancreatic epithelia and pos-
sibly by other CFTR-expressing epithelia.
Recently, a large number of PDZ domain-containing proteins
were identified in neuronal cells, especially in the postsynaptic
density (PSD) of excitatory synapses. Although limited infor-
mation is available up to now, in general, organization by
PDZ-based scaffolds allows the stable localization of interact-
ing proteins and enhances the rate and fidelity of signal trans-
duction (7). Because both neurons and epithelia share many
common features, such as ectodermal origin and polarized in-
tracellular structures, it is predicted that some of these scaf-
folds are expressed in epithelial cells and that they mediate
protein-protein interaction. In this study, we aimed to identify
the PDZ domain-containing proteins expressed in secretory
epithelia and to further characterize their roles in transepithe-
lial ion transport using integrated molecular, biochemical, and
physiological approaches.
In an exploratory RT-PCR, it was found that pancreatic
epithelia express the mRNAs of several PDZ domain-contain-
ing proteins, including SAP97, PSD-95, and Shank2. Of these,
Shank2, an isoform of the recently identified family of multi-
modular adaptors (11), showed an association with CFTR
through its PDZ domain in the yeast two-hybrid system and in
the mammalian cells. Measurements in CFTR-expressing NIH
3T3 cells revealed that Shank2 overexpression suppressed the
cAMP-induced phosphorylation and activation of CFTR. In ad-
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dition, antisense-Shank2 treatment augmented the CFTR-de-
pendent Cl transport in T84 epithelial cells, in which CFTR
and Shank2 are endogenously expressed. The above results
indicate that Shank2 mediates inhibitory regulation of CFTR
and that this may play an important role in epithelial
homeostasis.
EXPERIMENTAL PROCEDURES
Materials—The HA-tagged full-length pcDNA3.1-rShank2/CortBP1
construct has been described previously (12). Rabbit polyclonal anti-
Shank2 1136 sera were raised against the SAM region of Shank2.
To generate H6 fusion proteins for immunization, aa 1012–1252 of
rShank2 was amplified by PCR and subcloned into pRSETB (Invitro-
gen), and fusion proteins were purified using Probond resin (Invit-
rogen). The specificity of the Shank2 antibody was confirmed by immu-
noblotting on Shank isoforms expressed in heterologous cells as de-
scribed previously (13). M3A7 monoclonal antibody against the NBD2
domain and 24-1 monoclonal antibody against the C terminus of CFTR
were purchased from Upstate Biotechnologies and R&D systems, re-
spectively. NIH 3T3 cells stably expressing CFTR (1) were kindly pro-
vided by Dr. Michael J. Welsh (University of Iowa, Iowa City, IA) and
were maintained in Dulbecco’s modified Eagle’s medium containing 10
mM glucose and 10% fetal calf serum. For the stable expression of
Shank2, NIH 3T3 cells were transfected with pcDNA3.1-rShank2 con-
structs and selected with G418. T84 cells originated from human colonic
epithelia were purchased from the American Type Culture Collection
(ATCC) and maintained in a 1:1 mixture of Ham’s F-12 medium and
DMEM supplemented with 5% fetal calf serum.
Yeast Two-hybrid Analysis—The yeast two-hybrid assay was per-
formed as described earlier (14). The L40 yeast strain harboring re-
porter genes HIS3 and LacZ, under control of the upstream LexA
DNA-binding domain, was used in the assay. To semi-quantify the
interaction, HIS3 activity was determined by the percentage of yeast
colonies growing on histidine-lacking medium. For pBHA (a bait vector
containing the LexA DNA-binding domain) constructs, cDNA sequences
containing about 30 aa of the C terminus of membrane proteins were
amplified by PCR and subcloned in-frame into pBHA: rNBCn1 (aa
1190–1218: KYSPEKPVSVTINFEDEPSKKYMDAETSL), mDRA (aa
728–757: QEKERKFDFTINTNGGLRNRECQVPVETKF), hCFTR (aa
1452–1480: HRNSSKCKSKPQIAALKEETEEEVQDTRL), hNHE3 (aa
800–831: PFRLSNKSVDSFLQADGPEEQLQPASPESTHM), hVIP re-
ceptor (aa 467–495: TCSTQVSMLTRVSPGARRSSSFQAEVSLV), and
rSecretin receptor (aa 421–449: SFSNATNGPTHSTKASTEQSRSI-
PRASII). The pGAD10 (a prey vector, Clontech) constructs containing
the PDZ domains of SAP97, PSD-95, and Shank2 were previously
described (12, 14, 15).
RT-PCR—RT-PCR analysis was performed using rat pancreatic tis-
sues and isolated pancreatic duct cells as reported previously (8). The
primer sequences used for this study were as follows: 1) rSAP102, sense
(GTA CCC GGC AAG AAC ACC CCA AAA CTC AAC), antisense (CCG
CAC CAC CAA CCG CAC CAC A), PCR product 432 bp; 2) rSAP97,
sense (GTC GTC CTG CCC TCC ACA CCA CA), antisense (CCT TCC
GCC TTT TCA CAT ATA ATC GCA CTA), PCR product 376 bp; 3)
rGKAP, sense (GAG GCC GTT CAA AGG TCC GTG TGC), antisense
(GGG GCC CTT CGC TCC TTC TTG TCA), PCR product 395 bp; 4)
rPSD-93, sense (AAG ACT TCC CTG CCG CCC ATC C), antisense
(TGC CCC GCC CCC TTC AGT G), PCR product 530 bp; 5) rPSD-95,
sense (CCC CAG CCT CCC TTC CCA CCC TTC TTA TTT), antisense
(ATG GGG AGT TAT GAT GGG GCA GGG GTG AC), PCR product 373
bp; 6) rShank1, sense (TCT TAT AGG GGG AGC TTT GGA CAC AGG
A), antisense (GAC GGG GGA CAG CAG CAT CAC AGG), PCR product
366 bp; 7) rShank2, sense (CCC CGC AGC CGC TCT CCC TCA CT),
antisense (CCG CCC TCG CCG ATG CTC AGA ACT T), PCR product
278 bp; 8) rS-SCAM, sense (ACA GGC AGC CAC AGG ATT TTG ATT
ATT T), antisense (CAG GCG TGG GGT TCG TCG TGT CTT TAG),
PCR product 402 bp.
Immunohistochemistry—The pancreas and colon tissues from
Sprague-Dawley rats were embedded in OCT (Miles, Elkhart, IN),
frozen in liquid N2, and cut into 4-m sections. Immunostaining of
frozen sections was performed as previously reported (8). Briefly, the
sections were fixed and permeabilized by incubation in cold methanol
for 10 min at 20 °C. Nonspecific binding sites were blocked by incu-
bation for 1 h at room temperature with 0.1 ml of phosphate-buffered
saline containing 5% goat serum, 1% bovine serum albumin, and 0.1%
gelatin (blocking medium). After blocking, the sections were stained by
incubating them with anti-Shank2 1136 and/or anti-CFTR 24–1 anti-
bodies and then treated with fluorophore-tagged secondary antibodies.
Images were obtained with a Zeiss LSM 510 confocal microscope.
Immunoblotting and Immunoprecipitation—Pre-cleared pancreatic
or NIH 3T3 lysates were mixed with the appropriate antibodies and
incubated overnight at 4 °C in lysis buffer. Immune complexes were
collected by binding to mixed protein A/G beads and were washed four
times with lysis buffer prior to electrophoresis. The lysis buffer contains
(in mM) HEPES 50 (pH 7.4), NaCl 150, EDTA 1, Nonidet P-40 1% (v/v),
glycerol 10% (v/v), and the complete protease inhibitor mixture (Roche
Applied Science, Mannheim, Germany). The immunoprecipitates or
lysates were suspended in SDS sample buffer and separated by SDS-
PAGE. The separated proteins were transferred to polyvinylidene di-
fluoride membranes, and the membranes were blocked by a 1-h incu-
bation at room temperature in a blocking solution containing 5% nonfat
dry milk. The membranes were then incubated with the appropriate
primary and secondary antibodies, and protein bands were detected by
enhanced chemiluminescence solutions (Amersham Biosciences). The
staining intensities of immunoblots were analyzed using imaging soft-
ware (MCID version 3.0; Brock University, St. Catharine’s, Ontario,
Canada).
Site-directed Mutagenesis—Oligonucleotide-directed mutagenesis
was performed using QuikChange kit (Stratagene) with pcDNA3.1-
rShank2 plasmid according to the manufacturer’s protocol. His-109
residue of rShank2 was substituted with different amino acids. The
mutagenesis primers were as follows: H109A, CAA TGA AAA TGT CGT
CAA GGT GGG CGC CAG GCA GGT GGT GAA CAT GAT CCG;
H109R, GAA AAT GTC GTC AAG GTG GGC CGC AGG CAG GTG
GTG AAC ATG ATC; and H109Q, GAA AAT GTC GTC AAG GTG GGC
CAA AGG CAG GTG GTG AAC ATG ATC. Corresponding antisense
primers were also made and used for the PCR reactions to generate
plasmids with mutated sequences.
Measurement of Cl Channel Activities—Whole cell recordings were
performed on CFTR-expressing NIH 3T3 cells after they had been
stably transfected with pcDNA3.1-rShank2 or mock plasmids. The pi-
pette solution contained (in mM) 140 N-methyl-D-glucamine chloride
(NMDG-Cl), 5 EGTA, 1 MgCl2, 1 Tris-ATP, and 10 HEPES (pH 7.2), and
the bath solution contained 140 NMDG-Cl, 1 CaCl2, 1 MgCl2, 10 glu-
cose, and 10 HEPES (pH 7.4). All experiments were performed at room
temperature (22–25 °C). After establishing the whole cell configuration,
CFTR was activated by adding 5 M forskolin. Currents were digitized
and analyzed using an AxoScope 8.1 system and a Digidata 1322A
AC/DC converter. Mean currents were normalized as current densities
(pA/picofarad (pF)).
Measurement of Cl/HCO3
 Exchange—Cl/HCO3
 exchange activity
was measured by recording the intracellular pH (pHi) in response to
[Cl]o changes of the perfusate, as previously detailed (16). Typically,
the first 10–40 s of the initial linear portion of pHi increases due to
Cl-dependent intracellular uptake of HCO3
 were fitted to a linear
equation using the Felix software (version 1.4; PTI Inc.) and expressed
as pH units/min. Cell-attached glass coverslips were washed once with
HEPES-buffered solution A and assembled to form the bottom of a
perfusion chamber. The HEPES-buffered solution A contained (in mM)
140 NaCl, 5 KCl, 1 MgCl2, 1 CaCl2, 10 glucose, and 10 HEPES (pH 7.4).
NIH 3T3 cells were loaded with a fluorescent pH probe BCECF by
incubating them for 10 min at room temperature in solution A contain-
ing 2.5 M BCECF-AM. After dye loading, the cells were perfused with
a HCO3
-buffered solution and BCECF fluorescence was recorded at
excitation wavelengths of 490 and 440 nm at a resolution of 2/s using a
recording setup (Delta Ram; PTI Inc.). The HCO3
-buffered solution
containing (in mM) 120 NaCl, 5 KCl, 1 MgCl2, 1 CaCl2, 10 glucose, 5
HEPES, 25 NaHCO3 (pH 7.4) was continuously gassed with 95% O2 and
5% CO2. Cl
-free solutions were prepared by replacing Cl with gluco-
nate. The 490/440 ratios were calibrated intracellularly by perfusing
the cells with solutions containing 145 mM KCl, 10 mM HEPES, and 5
M nigericin with pH adjusted to 6.2–7.6.
Biotinylation of Surface Membrane Proteins—Surface biotinylation
of glycosylated CFTR was performed as described by Lisanti et al. (17)
with minor modifications. Briefly, cells were washed with ice-cold phos-
phate-buffered saline containing 0.1 mM CaCl2 and 1 mM MgCl2 and
then incubated with 10 mM NaIO4 for 30 min at 0 °C in the dark to
increase acceptability of biotin to glycoside moiety. The cells were then
washed and biotinylated using EZ-Link biotin-LC-hydrazide (Pierce, 2
mg/ml in solution A) for 30 min at room temperature. Free biotin was
washed out twice with a glycine-containing solution (100 mM glycine, 10
mM Tris-HCl, pH 7.4) and then with ice-cold phosphate-buffered saline.
For time-course experiments, cells were incubated with DMEM media
for 2, 8, 18, or 24 h and lysed with a lysis buffer (1% Triton X-100, 50 mM
EGTA, 134 mM NaCl, 10 mM Tris-HCl, pH 7.4, with complete protease
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inhibitor cocktails). The lysates were centrifuged for 10 min (13,000 
g), and the pellet was discarded. Avidin solution (UltraLink Immobi-
lized NeutrAvidin beads 10%, Pierce, 200 l) was added to the super-
natant (500 g of protein in 500 l of lysis buffer), and the mixture was
incubated overnight with gentle mixing at 4 °C. Avidin-bound com-
plexes were pelleted (13,000  g) and washed three times. Biotinylated
proteins were eluted in Laemmli buffer, resolved by SDS-PAGE, elec-
trotransferred, and immunoblotted with the anti-CFTR antibody
M3A7.
32P Labeling of CFTR Protein—NIH 3T3 cells grown in 6-well plates
were incubated in a phosphate-free DMEM supplemented with 0.5
mCi/ml [32P]orthophosphate (PerkinElmer Life Sciences) for 3 h at
37 °C. The cells were then washed with DMEM and treated with the
phosphatase inhibitor NaVO4 (1 mM) and the designated concentrations
of forskolin for 10 min. The 32P-labeled lysates (1 mg of protein) were
immunoprecipitated with M3A7 CFTR antibody, separated by 6% SDS-
PAGE, and visualized by autoradiography.
Antisense mRNA for hShank2 in T84 Cells—Antisense mRNA was
expressed in T84 cells to reduce human Shank2 expression. The com-
mon 217-bp regions of the two identified splicing variants of hShank2
(NM012309 and NM133266) covering the initiation codon, were se-
lected as target sequences. The target sequences were amplified by PCR
and subcloned into pcDNA3.1 vector in the reverse direction using the
XhoI and BamHI sites. The primer sequences were as follows: sense
(BamHI), CGG GAT CCA TGA TGA TGA ACG TCC CCG; antisense
(XhoI), CCG CTC GAG CTG GGA AAG CCG GTG TTG G. Stable
transfectants were selected using G418 and the reduced expressions of
Shank2 were confirmed by immunoblotting.
Statistical Analysis—Results are presented as the means  S.E. of
the indicated number of experiments. The results of multiple experi-
ments were analyzed using the non-paired Student’s t test or analysis
of variance as appropriate.
RESULTS
Expression of PDZ-based Scaffolds in Pancreatic Epithelia—In
previous studies, we reported that interactions between multiple
membrane proteins, which have PDZ-binding motif on their C
terminus perform important roles in pancreatic bicarbonate secre-
tion (8–10). Therefore, as an initial step, we analyzed the expres-
sions of PDZ domain-containing proteins in pancreatic epithelia by
RT-PCR using brain tissue as a positive control. As shown in Fig.
1A, rat pancreatic tissue expressed the mRNAs of SAP97, PSD-95,
and Shank2. However, pure pancreatic duct cells isolated by mi-
crodissection showed only the mRNA of Shank2. Occasionally, a
faint band of guanylate kinase-associated protein (GKAP) was ob-
served in samples from pancreatic tissue. The expression of Shank2
in pancreatic tissue was further confirmed by immunostaining
(Fig. 1B). Of interest, Shank2 was found to be principally localized
in the luminal (apical) pole of large and small pancreatic ducts. A
weaker expression was also detected in the luminal area of pancre-
atic acinar cells (Fig. 1B).
Protein-Protein Interaction between PDZ-based Scaffolds
and Membrane Proteins—Possible interactions between the C
termini of membrane proteins in pancreatic epithelia and the
PDZ domains of SAP97, PSD-95, and Shank2 were screened by
the yeast two-hybrid assay. Peptide sequences of class I PDZ-
binding motif of the membrane proteins are listed under “Ex-
perimental Procedures.” To estimate the intensity of the pro-
tein interactions, HIS3 activity was determined by the
percentage of yeast colonies growing on histidine-lacking
TABLE I
Yeast two-hybrid assay
HIS3 activity was determined by the percentage of yeast colonies
growing on histidine-lacking medium to estimate the intensity of pro-
tein-protein interactions between the PDZ domains of adaptor proteins
and the C terminus of membrane proteins. After the transfection with
the prey and bait vectors, equal amounts of yeast cells were plated on
histidine-lacking and histidine-supplemented media. The number of
yeast colonies growing on histidine-lacking medium was divided by that
of growing on histidine-supplemented medium and expressed as per-
centage.
Membrane protein
HIS3 activity
pGAD10,
alonea
SAP97,
PDZ1–2
PSD-95,
PDZ1–3
Shank2,
PDZ
%
CFTR 0 0 0 33
NHE3 0 0 0 44
NBCn1 0 1 2 44
DRA 0 0 0 0
VIP receptor 0 1 11 0
Secretin receptor 0 0 0 0
a Empty pGAD10 was used as negative control.
FIG. 1. Expression of PDZ domain-containing proteins in pancreatic epithelia. A, RT-PCR analyses of PDZ domain-containing proteins
identified in the PSD of excitatory synapses were performed on rat pancreatic tissues and on isolated pancreatic ducts. Rat brain tissue samples
were used as positive controls. B, expression of Shank2 in pancreatic tissues was examined by immunostaining using anti-Shank2 1136 antibody
and fluorescein isothiocyanate-labeled goat anti-rabbit IgG sera. Note that Shank2 was localized in the luminal pole of the large (left) and the small
(right) pancreatic duct cells, and that this was absent from the samples incubated with H6-rShank2-(1012–1252) fusion proteins used for
immunization (bottom). M, molecular maker.
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(His) medium with empty pGAD10 as negative controls. Pos-
itive colonies (His growth) were confirmed twice by the -ga-
lactosidase activity. In the yeast two-hybrid screening, Shank2
showed a strong association with CFTR, NHE3, and NBCn1
(Table I). Among the possible Shank2-associated membrane
transporters, we chose CFTR for further studies, because
CFTR is known to perform a central role in luminal ion trans-
port and to have regulatory functions on the other two trans-
porters, NHE3 and NBCn1 (8, 10). To verify the interaction
between CFTR and Shank2 in mammalian cells, CFTR-ex-
pressing NIH 3T3 cells were stably transfected with
pcDNA3.1-rShank2 or with mock plasmids, and immuno-
precipitation (IP) experiments were performed. As shown in
Fig. 2A, transfection of pcDNA3.1-rShank2 induced expression
of Shank2 protein in NIH 3T3 cells (arrowhead). Notably, large
amounts of CFTR proteins were detected in anti-Shank2 IP
samples from Shank2-transfected cells (Fig. 2A, right). Co-IP
experiments using antibodies in reverse order also demon-
strated the association between Shank2 and CFTR (see
Fig. 2B).
It has been reported that the first histidine residue of the
second -helix of PDZ domain (position B1, His-109 in
rShank2) plays an important role in class I PDZ interaction by
forming a strong hydrogen bond between its N-3 nitrogen and
the hydroxyl group of the 2 serine/threonine residue of the
ligand (18). To verify the importance of the PDZ-domain in
CFTR-Shank2 interaction, we substituted His-109 with two
other amino acids containing nitrogen side chain (H109R and
H109Q) and with a hydrophobic amino acid (H109A) and then
measured the protein-protein interaction by IP. As shown in
Fig. 2B, CFTR-Shank2 interactions were abolished in H109R
and H109A mutants by 78 8% and 96 3%, respectively (n
4). Therefore, it was concluded that PDZ-based interactions are
required for CFTR-Shank2 binding.
Inhibition of CFTR-dependent Anion Transport by
Shank—It is well known that CFTR protein has a cAMP-
activated Cl channel function (1). Thus, the cAMP-activated
chloride channel activities of CFTR-expressing NIH 3T3 cells
were measured in the whole cell configuration after they had
been stably transfected with pcDNA3.1-rShank2 or mock plas-
mids. Treatment with the adenylyl cyclase activator forskolin
produced a large inward current in NMDG-Cl solutions with
linear I-V relationships (Figs. 3, A and B). Further treatment
with 5-nitro-2-(3-phenylpropylamino)benzoic acid (30 M) in-
hibited this current by 94  3% (not shown). These character-
istics were in line with previous observations of CFTR Cl
currents (2). Interestingly, Shank2 overexpression decreased
the CFTR current densities (pA/pF) by 53% (Fig. 3C).
Recently, it was found that CFTR plays an important role in
transepithelial HCO3
 transport by regulating Cl/HCO3
 ex-
change (2, 19). Moreover, reduced HCO3
 secretion by defective
CFTR-dependent HCO3
 transport has been suggested to be an
important pathological mechanism in mutant CFTR-induced
respiratory and pancreatic diseases (21, 22). Therefore, Cl/
HCO3
 exchange activities were measured in NIH 3T3 cells by
estimating the pHi increase due to Cl
 removal from HCO3
-
buffered perfusate. As reported earlier (2), the Cl/HCO3
 ex-
change activities of CFTR-expressing NIH 3T3 cells were
highly increased by forskolin stimulation (Fig. 4B), but those of
CFTR-non expressing cells were unchanged (Fig. 4A). The ba-
sal and forskolin-stimulated activities of CFTR-expressing
NIH 3T3 cells were 0.121  0.026 pH unit/min and 0.865 
0.150, respectively. In Shank2-overexpressing cells, basal ac-
tivity (0.079  0.018, p  0.22) was not significantly changed
compared with mock transfected cells. However, similar to the
results of whole cell Cl currents, Shank2 overexpression de-
creased the cAMP-activated Cl/HCO3
 exchange (0.398 
0.093, p  0.02) in CFTR-expressing NIH 3T3 cells (Fig. 4D).
Molecular Mechanisms Responsible for the Decreased CFTR
Activity—Two possibilities were examined to explain the un-
derlying molecular mechanisms of inhibitory effects of Shank2
on CFTR-dependent anion transporting activities. The first
possibility involves the reduced membrane expression of CFTR
protein. Because Shank2 is known to be associated with cy-
toskeletal proteins (11), it may affect sorting, trafficking, or the
endocytotic recycling of CFTR protein. Membrane proteins
were biotinylated and harvested at the designated times and
FIG. 2. Immunoprecipitation of Shank2 and CFTR in NIH 3T3
cells. A, proteins from CFTR-expressing NIH 3T3 cells stably trans-
fected with pcDNA3.1-rShank2/CortBP1 or mock plasmids were precip-
itated with anti-Shank2 1136 antibody, and then blotted with the
anti-CFTR M3A7 antibody. A blot of immunoprecipitated samples is
shown in the right panel and control immunoblots of Shank2 and CFTR
are presented in the left and middle panels, respectively. B, His-109 of
rShank2 (position B1 in the class I PDZ domain) was substituted with
Arg, Gln, and Ala, and Shank2-CFTR binding was measured by immu-
noprecipitation (IP). Note that IP in panel B was performed using a
different antibody order from that in panel A. In all immunoblotting
experiments, 100 g of protein was loaded into each lane, and IP was
performed using a total of 1 mg of lysate. FIG. 3. Inhibition of CFTR Cl
 channel activity by Shank2 in
NIH 3T3 cells. Cl channel activities were measured in CFTR-express-
ing NIH 3T3 cells stably transfected with pcDNA3.1-rShank2/CortBP1
or mock plasmids in the whole cell configuration. A, forskolin treatment
produced an inward current in the NMDG-Cl solutions at a holding
potential of 30 mV. B, linear I-V relationships were observed when a
ramp pulse from 50 mV to 50 mV was applied at peak current. C,
peak currents were normalized as current densities (pA/pF) and the
results of 8 (Mock) and 10 (Shank2) experiments are summarized in
panel C.
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then blotted with anti-CFTR M3A7 antibody (Fig. 5A). In con-
trast to our expectations, Shank2 overexpression showed a
tendency to increase the membrane expression of CFTR by 39 
28% (p  0.11, at 2 h after biotinylation) and to extend the
half-life of the biotinylated CFTR protein from 17.2 to 25.4 h (p
0.13, Fig. 5B), although neither of them reached the statistical
FIG. 5. Surface biotinylation and phosphorylation of CFTR in NIH 3T3 cells. A and B, membrane proteins were biotinylated for 30 min
and harvested at pre-set times. Biotinylated proteins were resolved by SDS-PAGE and immunoblotted with the anti-CFTR M3A7 antibody.
Degradation of surface CFTR protein in pcDNA3.1-rShank2 or mock-transfected cells was estimated treating each band intensity at 2 h as 100%.
Results of three experiments are summarized in panel B. C and D, 32P labeling of CFTR protein was performed in NIH 3T3 cells stimulated with
forskolin. Individual phosphorylation levels were compared with the basal level (0 M forskolin) in mock transfected cells, and the results of four
experiments are summarized in panel D. *, p  0.05; **, p  0.01; difference from mock.
FIG. 4. Inhibition of CFTR-depend-
ent Cl/HCO3
 exchange by Shank2 in
NIH 3T3 cells. CFTR-dependent Cl/
HCO3
 exchanges were analyzed in NIH
3T3 cells by measuring the increase in
intracellular pH (pHi) in response to
[Cl]o removal from the HCO3
-containing
perfusate (25 mM HCO3
, continuously
gassed with 95% O2 and 5% CO2). The
Cl/HCO3
 exchange activities of CFTR-
expressing NIH 3T3 cells were markedly
increased by forskolin stimulation (B),
but those of CFTR-non expressing cells
were unchanged (A). Shank2 overexpres-
sion reduced forskolin-stimulated Cl/
HCO3
 exchange (B–D).
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significance. Nonetheless, the results of biotinylation experi-
ments did not explain the reduced CFTR activity by Shank2.
The second possibility of the reduced CFTR activity would be
the decreased cAMP-induced phosphorylation of CFTR upon
Shank2 expression. It is widely accepted that cAMP/PKA-in-
duced phosphorylation performs critical roles in CFTR activa-
tion (23). To measure the levels of phosphorylation, 32P labeling
of CFTR protein was performed in NIH 3T3 cells (nominally in
vivo phosphorylation assay) by stimulating with forskolin and
treating with the phosphatase inhibitor NaVO4 (Fig. 5C). A
control CFTR immunoblotting was performed to verify that
similar amounts of CFTR protein were loaded in each lane (Fig.
5C, bottom panel). In each experiment, the phosphorylation
levels of individual lanes were compared with the basal level (0
M forskolin) in mock transfected cells, and the summarized
results of four experiments are illustrated in Fig. 5D. Of note,
Shank2 overexpression decreased the cAMP-induced phospho-
rylation of CFTR as well as the basal phosphorylation. Hence,
it was concluded that the down-regulation of CFTR activity by
Shank2 was possibly due to the reduced cAMP-induced phos-
phorylation of CFTR.
CFTR-Shank2 Interaction in Colonic Epithelia—Either hy-
per- or hypofunction of CFTR perturbs the epithelial homeo-
stasis (4, 5). Concerning the inhibitory regulation of Shank2 on
CFTR, colonic epithelia will be the most relevant tissue to
examine the physiological role of Shank2, where hyper-func-
tioning of CFTR causes severe life-threatening conditions such
as cholera (5, 24). Initially, we investigated the expression of
Shank2 in rat colonic mucosa. As shown in Fig. 6A, Shank2 was
expressed in colonic mucosa, in fact, higher amounts of CFTR-
Shank2 IP products were observed in samples from colonic
mucosa than in those from the pancreatic tissue, possibly due
to the higher amount of CFTR protein in the colonic mucosa.
The expression pattern of Shank2 was determined immunohis-
tochemically by double staining with anti-Shank2 and anti-
CFTR antibodies (Fig. 6B). In general, colonic surface epithelia
absorb fluids and electrolytes, whereas crypt cells secrete (5).
Shank2 was expressed in both surface and crypt cells, although
CFTR was expressed principally in crypt cells. As was found in
pancreatic epithelia (Fig. 1B), Shank2 was observed in the
luminal area of colonic epithelia. Therefore, merged images in
cross sections and in longitudinal sections showed that Shank2
and CFTR were highly co-localized in the luminal area of crypt
cells (Fig. 6B).
To determine whether the Shank2-mediated inhibition of
CFTR has physiological relevance, we attempted to remove
Shank2 from colonic T84 cells by stably transfecting antisense-
hShank2 clones. As shown in Fig. 7A, antisense-Shank2 treat-
ment caused an average reduction of 79  8% in Shank2
protein expression in T84 cells. We next examined the effects of
Shank2 loss on CFTR activity by whole cell patch-clamp stud-
ies. A summary of the Cl current recordings taken at a hold-
ing potential of 40 mV is presented in Fig. 7B. Interestingly,
only a proportion of T84 cells showed significant CFTR Cl
channel activities. We regarded the cells showed the forskolin-
stimulated current densities over 5 pA/pF as “CFTR-positive,”
and analyzed their values for evaluating the effects of Shank2
expression. The proportion of CFTR-positive cells was not dif-
ferent between the mock and the antisense-Shank2-treated
cells (7/24 and 5/14, respectively; p  0.72 by Fisher’s exact
test). In all experiments, the viability of cells was verified by
observing volume-sensitive Cl channel activities evoked by
260 mosM bath solutions after the forskolin treatment. Notably,
loss of Shank2 by antisense treatment augmented CFTR cur-
rents in T84 cells, in which Shank2 and CFTR are endog-
enously expressed. Forskolin (5 M) produced an average in-
FIG. 6. Expression of Shank2 in rat
colonic mucosa. A, expressions of CFTR
(bottom) and Shank2 (middle) were com-
pared in rat pancreatic tissue and colonic
mucosa by immunoblotting (each 100 g
of protein). In the immunoprecipitation
experiment (upper), samples from colonic
mucosa showed a 3.1 times thicker band
intensity than those from the pancreas
tissue (each performed with 2 mg of pro-
tein). B, immunostaining for Shank2 in
colonic mucosa was performed using anti-
Shank2 1136 (red) and anti-CFTR 24–1
(green) antibodies. S, surface cells; C,
crypt cells; B, basolateral membrane; L,
luminal membrane.
FIG. 7. Measurement of CFTR activity in antisense-hShank2
treated T84 cells. A, the stable transfection of antisense-hShank2
reduced Shank2 protein expression by 79  8% in T84 cells (n  3). B,
summarized results of whole cell Cl channel recordings in T84 cells
taken at a holding potential of 40 mV. Cells were stimulated with
forskolin (5 M), and peak currents were normalized as current densi-
ties. C, representative traces of I-V relationships (step pulse from 120
mV to 120 mV with 20-mV intervals) obtained from cells having
median value of each group. **, p  0.01; difference from mock.
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ward current of 19.3  2.9 pA/pF at a 40 mV holding
potential in mock transfected cells, and this value was in-
creased to 37.3  3.7 pA/pF (p  0.01) in antisense-hShank2-
transfected cells (Fig. 7B). Traces of I-V relationships obtained
from cells having median value of each group are shown in Fig.
7C. Forskolin treatment evoked an inward current in
NMDG-Cl solutions with linear I-V relationships. In addition,
an average inhibition of 91% of this current by glibenclamide
(100 M) demonstrated that most of the observed currents were
induced by CFTR.
DISCUSSION
Assembly of specific proteins at the microdomains of intra-
cellular regions is powerful machinery that enables the cell to
function properly as well as to form unique subcellular struc-
tures. One of the critical components of these protein complexes
is the modular adaptor proteins. Recently, a family of PDZ-
based adaptors has been identified by several investigators and
named independently as Shank, CortBP, or ProSAP (11, 25,
26). Subsequent studies revealed that the Shank family of
proteins has many binding partners especially in the PSD of
excitatory synapses (12). For example, Shank interacts directly
with GKAP and Homer, thus potentially bridging the NMDA
receptor and the metabotropic glutamate receptors in neurons
(27). However, the results of present study demonstrate that
the role of Shank as a molecular scaffold is not limited to the
neuronal systems.
The most notable finding in this study is the inhibition of
CFTR activity by Shank2. CFTR-dependent Cl channel activ-
ities and Cl/HCO3
 exchange activities were decreased by
Shank2 overexpression in CFTR-expressing NIH 3T3 cells
(Figs. 3 and 4). In addition, cAMP-induced phosphorylation of
CFTR was decreased by Shank2 in the heterologous expression
system (Fig. 5, C and D). Importantly, loss of Shank2 by anti-
sense-Shank2 treatment increased CFTR-mediated Cl chan-
nel activities in colonic T84 cells, in which epithelial properties
were retained (Fig. 7). All the above findings suggest that
Shank2 has a tonic inhibitory effect on the anion-transporting
activities of CFTR. Considering the fact that uncontrolled hy-
peractivation of CFTR evokes life-threatening secretory diar-
rhea, Shank2 may play a significant role in the homeostatic
regulation of CFTR activity at least in colonic epithelia.
As to the experiments in T84 cells, we found that there are
considerable degrees of heterogeneity of CFTR activity between
batches. In fact, we measured the CFTR Cl channel activity in
T84 cells from three different sources. Among them, a batch
obtained directly from ATCC (CCL-248, lot number 2056314)
showed the highest CFTR activity in terms of both the fre-
quency of CFTR-positive cells and the amplitude of CFTR Cl
currents. Therefore, stable transfection of antisense-Shank2
plasmid was introduced to this batch of T84 cells and functional
experiments were performed. However, low expression of
CFTR protein in T84 cells hampered the further molecular
analyses that had been conducted in NIH 3T3 cells. Although
the results in heterologous expression system do not always
match with native expression system, we speculate that signif-
icant analogy exists between these two systems, because ex-
pression of Shank2 inhibited CFTR activity in both NIH 3T3
and T84 cells.
The finding that a protein can bind to CFTR and inhibit its
activity is reminiscent of the relationship between syntaxin 1A
and CFTR (28). However, in several respects, the inhibitory
mechanism of Shank2 on CFTR is different from that of syn-
taxin 1A. For example, syntaxin 1A binds to the N-terminal
part of CFTR and is believed to regulate CFTR activity by
directly modulating the gating properties or by affecting mem-
brane trafficking of CFTR (29). On the contrary, Shank2 seems
to bind to the C-terminal PDZ-binding motif of CFTR (Table I
and Fig. 2B) and regulate its anion transporting activities by
inhibiting cAMP-induced phosphorylation (Fig. 5). The mech-
anisms responsible for the reduced cAMP-induced phosphoryl-
ation are currently under investigation. A plausible scenario is
that Shank2 associates with a phosphatase that can dephos-
phorylate CFTR. Alternative possibilities include the competi-
tion between Shank2 and CFTR-activating scaffolds at the C
terminus of CFTR. For example, PDZ-based scaffolds, such as
EBP50/NHERF1, E3KARP/NHERF2, or PDZK1/CAP70 have
been suggested to activate CFTR by facilitating protein kinase
A-induced phosphorylation or by forming active dimer (30–32).
Although the present study sufficiently showed that Shank2
decreased CFTR phosphorylation (Fig. 5), this does not com-
pletely rule out other possible mechanisms for the reduced
CFTR activity. For instance, Shank2 has a single PDZ domain,
hence it can hamper the reported active dimer formation by
multiple PDZ domain-containing scaffolds (32). The competi-
tive balance between Shank2-CFTR binding and EBP50-CFTR
binding (or E3KARP-CFTR or CAP70-CFTR) may maintain the
homeostatic regulation of CFTR.
By the yeast two-hybrid screening, it was found that Shank2
can associate with NHE3 and NBCn1 in addition to CFTR.
Notably, all of these transporters are localized in the luminal
membrane of pancreatic duct cells and actively participate in
transepithelial HCO3
 transport (8, 10). In fact, we observed
that Shank2 binds to NHE3, and that the overexpression of
Shank2 blunted the cAMP-induced inhibition of NHE3 activity
in the heterologous expression system of PS120 cells (not
shown). These findings imply that Shank2 works as a common
regulator for modulating ion and fluid transport in the luminal
membrane of epithelia, especially as a counterpart of cAMP-
evoked signals. Typically, the Shank family of proteins has
multiple protein-protein interaction sites and is characterized
by multiple ankyrin repeats, an SH3 domain, a PDZ domain, a
long proline-rich domain, and a sterile alpha motif (SAM) do-
main in N terminus to C terminus order. However, isoforms
and splicing variants of Shank showed a considerable degree of
variability in their domain compositions (11, 13). Although the
name of Shank originated from SH3 domain and ankyrin re-
peats, the major form of Shank2/CortBP1 found and used in
this study does not have SH3 or ankyrin repeat domains, but
does have the other three domains, including the PDZ domain.
Future studies identifying binding partners for these modular
domains may reveal more diverse roles of Shank2 proteins in
epithelial function.
In conclusion, we found that Shank2 binds to CFTR and
tonically inhibits the cAMP-induced activation of CFTR after
an integrated search for new PDZ-based scaffolds in epithelial
tissues. Because aberrant CFTR activity, especially uncon-
trolled hyper-functioning of CFTR evokes life-threatening con-
ditions such as diarrhea in cholera infection, the fine regulation
of CFTR activity by Shank2 will be important in maintaining
epithelial and body homeostasis.
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